- Home
- ENTX vs GNS Comparison
ENTX vs GNS Comparison
Compare ENTX & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- GNS
- Stock Information
- Founded
- ENTX 2010
- GNS 2002
- Country
- ENTX Israel
- GNS Singapore
- Employees
- ENTX 21
- GNS N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- GNS Other Consumer Services
- Sector
- ENTX Health Care
- GNS Real Estate
- Exchange
- ENTX Nasdaq
- GNS Nasdaq
- Market Cap
- ENTX 107.3M
- GNS 81.8M
- IPO Year
- ENTX 2018
- GNS 2022
- Fundamental
- Price
- ENTX $2.49
- GNS $0.88
- Analyst Decision
- ENTX Strong Buy
- GNS
- Analyst Count
- ENTX 1
- GNS 0
- Target Price
- ENTX $10.00
- GNS N/A
- AVG Volume (30 Days)
- ENTX 143.0K
- GNS 1.7M
- Earning Date
- ENTX 11-07-2025
- GNS 09-23-2025
- Dividend Yield
- ENTX N/A
- GNS N/A
- EPS Growth
- ENTX N/A
- GNS N/A
- EPS
- ENTX N/A
- GNS N/A
- Revenue
- ENTX $166,000.00
- GNS $5,749,894.00
- Revenue This Year
- ENTX N/A
- GNS $62.23
- Revenue Next Year
- ENTX N/A
- GNS $69.63
- P/E Ratio
- ENTX N/A
- GNS N/A
- Revenue Growth
- ENTX 191.23
- GNS N/A
- 52 Week Low
- ENTX $1.50
- GNS $0.21
- 52 Week High
- ENTX $2.95
- GNS $1.92
- Technical
- Relative Strength Index (RSI)
- ENTX 64.36
- GNS 46.98
- Support Level
- ENTX $2.25
- GNS $0.83
- Resistance Level
- ENTX $2.51
- GNS $0.93
- Average True Range (ATR)
- ENTX 0.20
- GNS 0.08
- MACD
- ENTX 0.04
- GNS -0.01
- Stochastic Oscillator
- ENTX 58.56
- GNS 25.29
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.